Every record from Janoshik · page 76
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2024-004304 | Sermorelin | QYB | QYB-2404-W5163 | 2024-Q2 | 99.17 | 3.70 | — | Laboratory-retained | 0 | PASS |
| AX-2024-005184 | LL-37 | SSA | SSA-2403-V6258 | 2024-Q2 | 98.46 | 2.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004295 | Melanotan II | QYB | QYB-2402-P5428 | 2024-Q2 | 99.93 | 6.06 | 93.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004238 | GHRP-6 | WWB | WWB-2401-U3578 | 2024-Q2 | 99.77 | 3.03 | 105.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004470 | GHRP-6 | FGP | FGP-2312-X1645 | 2024-Q2 | 99.44 | 5.06 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004467 | GHRP-6 | FGP | FGP-2312-X1645 | 2024-Q2 | 99.29 | 4.36 | 93.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005222 | IGF-1 DES (1-3) | SSA | SSA-2403-F6661 | 2024-Q2 | 98.94 | 3.46 | 99.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004718 | Semaglutide | Homopeptide | HOMO-2401-R8471 | 2024-Q2 | 99.08 | 2.60 | 104.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004537 | Semaglutide | JEEP | JEEP-2401-R2856 | 2024-Q2 | 99.15 | 8.39 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-004322 | AOD-9604 | QYB | QYB-2404-N6056 | 2024-Q2 | 99.93 | 1.99 | 106.9 | Supplier-supplied | 0 | PASS |
| AX-2024-005224 | IGF-1 DES (1-3) | SSA | SSA-2403-F6661 | 2024-Q2 | 99.63 | 3.96 | 107.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004999 | Semaglutide | GGPeps | GGPE-2404-D2105 | 2024-Q2 | 98.23 | 7.14 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004611 | Tirzepatide | TFC | TFC-2405-W5763 | 2024-Q2 | 97.07 | 5.29 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2024-004317 | Retatrutide | QYB | QYB-2312-K5632 | 2024-Q2 | 98.60 | 4.69 | 94.6 | Supplier-supplied | 4 | MARGINAL |
| AX-2024-004259 | Semaglutide | QYB | QYB-2311-U4777 | 2024-Q2 | 98.66 | 3.84 | 106.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004235 | GHRP-6 | WWB | WWB-2401-U3578 | 2024-Q2 | 99.80 | 2.68 | 89.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005274 | BPC-157 | SSA | SSA-2401-E8185 | 2024-Q2 | 99.08 | 5.77 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004866 | PT-141 (Bremelanotide) | SWB | SWB-2311-H6137 | 2024-Q2 | 99.21 | 3.18 | 97.4 | Supplier-supplied | 0 | PASS |
| AX-2024-004799 | L-Carnosine | Homopeptide | HOMO-2405-P1520 | 2024-Q2 | 99.52 | 6.22 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004464 | GHRP-6 | FGP | FGP-2312-X1645 | 2024-Q2 | 99.93 | 5.20 | 103.3 | Supplier-supplied | 0 | PASS |
| AX-2024-005337 | Tirzepatide | SGN | SGN-2401-K1375 | 2024-Q2 | 98.54 | 3.68 | 92.1 | Supplier-supplied | 3 | MARGINAL |
| AX-2024-005335 | Tirzepatide | SGN | SGN-2401-K1375 | 2024-Q2 | 98.86 | 4.99 | 103.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2024-005217 | IGF-1 DES (1-3) | SSA | SSA-2403-F6661 | 2024-Q2 | 99.68 | 4.52 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004289 | Melanotan II | QYB | QYB-2402-P5428 | 2024-Q2 | 99.93 | 5.71 | 99.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005532 | Semaglutide | BCH | BCH-2401-C7932 | 2024-Q2 | 98.09 | 5.79 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2024-005490 | Cagrilintide | BCH | BCH-2402-C7117 | 2024-Q2 | 98.89 | 4.22 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2024-004379 | Retatrutide | QSC | QSC-2404-P8297 | 2024-Q2 | 98.88 | 6.27 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2024-005472 | Semaglutide | BCH | BCH-2405-U6438 | 2024-Q2 | 97.96 | 4.31 | 90.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005033 | Humanin (HNG) | GGPeps | GGPE-2403-N2129 | 2024-Q2 | 99.22 | 3.41 | 103.6 | Supplier-supplied | 2 | FAIL |
| AX-2024-004797 | L-Carnosine | Homopeptide | HOMO-2405-P1520 | 2024-Q2 | 99.07 | 6.30 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005524 | Semaglutide | BCH | BCH-2401-C7932 | 2024-Q2 | 98.09 | 6.25 | 92.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004237 | GHRP-6 | WWB | WWB-2401-U3578 | 2024-Q2 | 99.93 | 3.15 | 98.8 | Supplier-supplied | 0 | PASS |
| AX-2024-005489 | Cagrilintide | BCH | BCH-2402-C7117 | 2024-Q2 | 97.59 | 2.64 | 91.1 | Laboratory-retained | 0 | PASS |
| AX-2024-004613 | Tirzepatide | TFC | TFC-2405-W5763 | 2024-Q2 | 97.71 | 5.96 | 90.9 | Laboratory-retained | 2 | MARGINAL |
| AX-2024-004662 | Tirzepatide | TFC | TFC-2312-P7493 | 2024-Q2 | 98.51 | 3.04 | 88.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004663 | Tirzepatide | TFC | TFC-2312-P7493 | 2024-Q2 | 98.10 | 3.01 | 98.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005038 | Humanin (HNG) | GGPeps | GGPE-2403-N2129 | 2024-Q2 | 98.96 | 4.04 | 99.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004229 | GHRP-6 | WWB | WWB-2401-U3578 | 2024-Q2 | 99.93 | 2.75 | 93.4 | Supplier-supplied | 0 | PASS |
| AX-2024-005083 | Semaglutide | MKM | MKM-2403-C3618 | 2024-Q2 | 98.18 | 6.09 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004450 | TB-500 | FGP | FGP-2402-X1108 | 2024-Q2 | 99.74 | 5.59 | 92.6 | Supplier-supplied | 1 | MARGINAL |